Icahn School of Medicine at Mount Sinai
The goal of this study is to assess the value of liver dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and texture analysis post gadopiclenol for liver fibrosis staging, in comparison with MR elastography, T1 mapping, ultrasound elastography and blood tests in 50 initial patients with metabolic dysfunction-associated steatohepatitis (MASH).
Metabolic dysfunction-associated steatotic liver disease (MASLD, formerly known as nonalcoholic fatty liver disease or NAFLD) is characterized by the accumulation of excess fat in the liver, ranging from mild forms like non-alcoholic fatty liver (NAFL) to more severe stages such as metabolic dysfunction-associated steatohepatitis (MASH, formerly known as nonalcoholic steatohepatitis or NASH) with associated inflammation, ballooning, fibrosis, and cirrhosis. The severity of MASH and increasing fibrosis stages is associated with higher morbidity and mortality rates. The study will compare dynami…
Inclusion Criteria: * Patients with suspected MASLD (F0-F4) with clinically indicated percutaneous or transjugular liver biopsy within 6 months of MRI (before or after MRI). * Both genders. * Age \> 18 years. * Any racial/ethnic background. Exclusion criteria: * Previous history or current diagnosis of HCC or decompensation. * Contraindications for MRI, including * Medically unstable * Intracranial clips * Metal implants * Suspected or confirmed metal in eyes * Cardiac pacemaker, implanted defibrillator, other implanted electronic device * Pregnancy: Pregnancy tests will be off…
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.